Matches in SemOpenAlex for { <https://semopenalex.org/work/W2196252189> ?p ?o ?g. }
Showing items 1 to 83 of
83
with 100 items per page.
- W2196252189 endingPage "65" @default.
- W2196252189 startingPage "56" @default.
- W2196252189 abstract "Present study efforts are focusing to develop the flurbiprofen fast dissolving tablets using sublimation method to enhance the dissolution rate. In this study an attempt was made to fasten the drug release from the oral tablets by incorporating the sublimating agents in the presence of crosspovidone as superdisintegrant and studied the effect on dissolution rate when compared to conventional tablets. In the present study, sublimated fast dissolving tablets were prepared by direct compression method. The prepared tablets were characterized for physical parameters and drug release behavior and the best formulation was subjected to pharmacokinetic studies. From in vitro drug release studies, the formulation F2 showed fast drug release of about 99.94±0.26% in 30 min, and disintegration time 34.42 ± 0.74 sec. The percent drug release in 15 min (Q 15 ) and initial dissolution rate for formulation F2 was 91.46±1.42%, 6.10%/min. The dissolution efficiency was found to be 53.44 and it is increased by 4.5 fold with F2 sublimated tablets. From the pharmacokinetic evaluation, the conventional tablets producing peak plasma concentration (C max ) was 9023.68±561.83 ng/ml at 3 h T max and F2 sublimated tablets showed C max 11126.71±123.56 ng/ml at 2 h T max . The area under the curve for the conventional and F2 tablets was 30968.42±541.52 and 42973.66±568.13 ng h/ml. Hence, the development of flurbiprofen fast dissolving tablets by sublimation method is a right way to enhance not only the dissolution rate but also the absorption rate." @default.
- W2196252189 created "2016-06-24" @default.
- W2196252189 creator A5011230981 @default.
- W2196252189 creator A5067143857 @default.
- W2196252189 date "2015-12-08" @default.
- W2196252189 modified "2023-09-27" @default.
- W2196252189 title "Formulation and Pharmacokinetics of Flurbiprofen Sublimated Fast Dissolving Tablets#" @default.
- W2196252189 cites W1986620536 @default.
- W2196252189 cites W2000106042 @default.
- W2196252189 cites W2007807223 @default.
- W2196252189 cites W2023872732 @default.
- W2196252189 cites W2050228113 @default.
- W2196252189 cites W2057047431 @default.
- W2196252189 cites W2062297205 @default.
- W2196252189 cites W2086615997 @default.
- W2196252189 cites W2107153428 @default.
- W2196252189 cites W2115040197 @default.
- W2196252189 cites W2172186850 @default.
- W2196252189 cites W2334039005 @default.
- W2196252189 doi "https://doi.org/10.2174/1874844901502010056" @default.
- W2196252189 hasPublicationYear "2015" @default.
- W2196252189 type Work @default.
- W2196252189 sameAs 2196252189 @default.
- W2196252189 citedByCount "4" @default.
- W2196252189 countsByYear W21962521892017 @default.
- W2196252189 countsByYear W21962521892018 @default.
- W2196252189 countsByYear W21962521892022 @default.
- W2196252189 countsByYear W21962521892023 @default.
- W2196252189 crossrefType "journal-article" @default.
- W2196252189 hasAuthorship W2196252189A5011230981 @default.
- W2196252189 hasAuthorship W2196252189A5067143857 @default.
- W2196252189 hasBestOaLocation W21962521891 @default.
- W2196252189 hasConcept C112705442 @default.
- W2196252189 hasConcept C14029885 @default.
- W2196252189 hasConcept C15744967 @default.
- W2196252189 hasConcept C178790620 @default.
- W2196252189 hasConcept C185592680 @default.
- W2196252189 hasConcept C192562407 @default.
- W2196252189 hasConcept C2781000538 @default.
- W2196252189 hasConcept C2781430271 @default.
- W2196252189 hasConcept C43617362 @default.
- W2196252189 hasConcept C542102704 @default.
- W2196252189 hasConcept C58437636 @default.
- W2196252189 hasConcept C71924100 @default.
- W2196252189 hasConcept C77281830 @default.
- W2196252189 hasConcept C88380143 @default.
- W2196252189 hasConcept C98274493 @default.
- W2196252189 hasConceptScore W2196252189C112705442 @default.
- W2196252189 hasConceptScore W2196252189C14029885 @default.
- W2196252189 hasConceptScore W2196252189C15744967 @default.
- W2196252189 hasConceptScore W2196252189C178790620 @default.
- W2196252189 hasConceptScore W2196252189C185592680 @default.
- W2196252189 hasConceptScore W2196252189C192562407 @default.
- W2196252189 hasConceptScore W2196252189C2781000538 @default.
- W2196252189 hasConceptScore W2196252189C2781430271 @default.
- W2196252189 hasConceptScore W2196252189C43617362 @default.
- W2196252189 hasConceptScore W2196252189C542102704 @default.
- W2196252189 hasConceptScore W2196252189C58437636 @default.
- W2196252189 hasConceptScore W2196252189C71924100 @default.
- W2196252189 hasConceptScore W2196252189C77281830 @default.
- W2196252189 hasConceptScore W2196252189C88380143 @default.
- W2196252189 hasConceptScore W2196252189C98274493 @default.
- W2196252189 hasIssue "1" @default.
- W2196252189 hasLocation W21962521891 @default.
- W2196252189 hasOpenAccess W2196252189 @default.
- W2196252189 hasPrimaryLocation W21962521891 @default.
- W2196252189 hasRelatedWork W1969876219 @default.
- W2196252189 hasRelatedWork W2044293800 @default.
- W2196252189 hasRelatedWork W2196252189 @default.
- W2196252189 hasRelatedWork W3017356119 @default.
- W2196252189 hasRelatedWork W3021369409 @default.
- W2196252189 hasRelatedWork W3097307756 @default.
- W2196252189 hasRelatedWork W376047094 @default.
- W2196252189 hasRelatedWork W623892 @default.
- W2196252189 hasRelatedWork W97031821 @default.
- W2196252189 hasRelatedWork W119512299 @default.
- W2196252189 hasVolume "2" @default.
- W2196252189 isParatext "false" @default.
- W2196252189 isRetracted "false" @default.
- W2196252189 magId "2196252189" @default.
- W2196252189 workType "article" @default.